ACHAOGEN INC's ticker is AKAOQ and the CUSIP is 004449104. A total of 107 filers reported holding ACHAOGEN INC in Q2 2017. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 100 | -98.9% | 0.00% | – |
| Q1 2019 | $4,000 | -80.0% | 9,234 | -44.0% | 0.00% | – |
| Q4 2018 | $20,000 | -88.6% | 16,499 | -62.5% | 0.00% | – |
| Q3 2018 | $175,000 | +173.4% | 43,963 | +496.4% | 0.00% | – |
| Q2 2018 | $64,000 | -93.0% | 7,371 | -89.5% | 0.00% | – |
| Q1 2018 | $909,000 | +479.0% | 70,096 | +380.3% | 0.00% | – |
| Q4 2017 | $157,000 | -68.7% | 14,593 | -53.5% | 0.00% | -100.0% |
| Q3 2017 | $501,000 | +2177.3% | 31,402 | +2969.6% | 0.00% | – |
| Q2 2017 | $22,000 | -96.6% | 1,023 | -96.0% | 0.00% | -100.0% |
| Q1 2017 | $649,000 | +6390.0% | 25,710 | +3191.9% | 0.00% | – |
| Q4 2016 | $10,000 | 0.0% | 781 | -51.2% | 0.00% | – |
| Q2 2015 | $10,000 | +400.0% | 1,601 | +666.0% | 0.00% | – |
| Q1 2015 | $2,000 | -94.4% | 209 | -92.5% | 0.00% | – |
| Q4 2014 | $36,000 | +3500.0% | 2,792 | +3777.8% | 0.00% | – |
| Q3 2014 | $1,000 | -50.0% | 72 | -52.3% | 0.00% | – |
| Q2 2014 | $2,000 | – | 151 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,281,152 | $13,759,572,000 | 14.48% |
| Foresite Capital Management III, LLC | 2,375,000 | $25,508,000 | 7.16% |
| Prosight Management, LP | 570,920 | $6,132,000 | 4.51% |
| NEA Management Company, LLC | 5,215,128 | $56,010,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 204,538 | $2,197,000 | 0.78% |
| Marcus Capital, LLC | 17,400 | $187,000 | 0.72% |
| Iguana Healthcare Management, LLC | 75,000 | $806,000 | 0.52% |
| FIRST MIDWEST BANK TRUST DIVISION | 374,007 | $4,017,000 | 0.50% |
| DSC Advisors, L.P. | 70,000 | $752,000 | 0.44% |
| Polar Capital LLP | 1,881,380 | $20,206,000 | 0.21% |